At Merck, we're following the science to tackle some of the world's greatest health threats. Get a glimpse of how we work to improve lives.
Explore current job opportunities at Merck. Learn more about careers in Business Support, Clinical, Engineering, Information Technology, Research & Development, Manufacturing and Marketing.
Merck aspires to be the premier research-intensive biopharmaceutical company in the world. Learn about our commitment to save and improve lives.
At Merck, we follow the science. Learn about Merck's research and products by getting to know the science, strategy and brains behind the innovations.
Trademarks appearing on this website are owned, licensed to, promoted or distributed by Merck, its subsidiaries or affiliates, except as noted.
Merck's online newsroom offers real-time news about Merck's prescription medicines, vaccines and consumer care products.
Merck's U.S. headquarters, worldwide office, adverse event, investors, media, supplies and animal health contact information.
Merck (NYSE: MRK), known as MSD outside of the United States and Canada, is commencing today, through a subsidiary, a cash tender offer to purchase all outstanding shares of common stock of Terns Pharmaceuticals, Inc. (“Terns”) (Nasdaq: TERN). On , Merck announced that it had entered into a definitive agreement to acquire Terns. Upon the successful closing of the tender offer ...
CD388 is an investigational long-acting, strain-agnostic antiviral agent currently in Phase 3, designed to prevent influenza infection in individuals at higher risk of influenza complications Acquisition aligns with Merck’s science-led business development strategy, diversifying and expanding the company’s pipeline Merck (NYSE: MRK), known as MSD outside of the United States and Canada ...